Boehringer Ingelheim submits first oncology compound, afatinib* for European approval
20 September 2012 | By Boehringer Ingelheim
Submission of a MAA to the EMA for approval of afatinib*...
List view / Grid view
20 September 2012 | By Boehringer Ingelheim
Submission of a MAA to the EMA for approval of afatinib*...
20 September 2012 | By Amgen
A new indication for Prolia® approved...
19 September 2012 | By Citigate Dewe Rogerson
Wellington Partners announces the successful first closing of its new Wellington Partners IV Life Science Fund...
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
18 September 2012 | By Azbil BioVigilant
Azbil BioVigilant has entered into a distribution agreement with Archilex...
18 September 2012 | By kdm communications limited
Tecan understands that flexibility is crucial to making laboratory automation work for you...
18 September 2012 | By Merck
“We are disappointed that we have not been able to move forward with the filing..."
18 September 2012 | By B&W Tek Inc
B&W Tek, Inc. is proud to announce the expansion of their Exemplar® smart spectrometer platform.
17 September 2012 | By Gerresheimer Group
The healthcare sector needs innovative packaging solutions. Gerresheimer’s comprehensive portfolio of products extends...
17 September 2012 | By GlaxoSmithKline
GSK has submitted a regulatory application in the European Union seeking approval of an additional indication for Synflorix™...
17 September 2012 | By Pfizer
14 abstracts for tofacitinib...
17 September 2012 | By BASF
Visit us at CPhI worldwide Oct. 9-11, 2012 Hall 4, Booth 4D17 Feria de Madrid, Spain...
14 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has announced the beta launch of its first social game on Facebook...
14 September 2012 | By Eisai
Fycompa (Perampanel) is the first anti-epileptic drug to target AMPA receptors in the brain...
13 September 2012 | By Roche
Roche has been recognised as the most sustainable healthcare company...